Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05936970
Prospective, Multi-Center, Observational, Whole Blood Specimen Collection Study in Participants with Rheumatoid Arthritis with Inadequate Response or Intolerance to a DMARD Starting a New BDMARD or TsDMARD Treatment +/- CsDMARD
Sponsor: Aqtual, Inc.
View on ClinicalTrials.gov
Summary
The primary goal of this study is to assess a cfDNA-based blood test using genetic, transcriptomic and/or epigenetic information to help doctors predict the best treatment options for rheumatoid arthritis (RA) patients with inadequate response or intolerance to previous therapies.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
1410
Start Date
2023-06-29
Completion Date
2025-12
Last Updated
2024-11-29
Healthy Volunteers
No
Conditions
Locations (1)
Arthritis and Osteoporosis Consultants of the Carolinas
Charlotte, North Carolina, United States